发明名称 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
摘要 A method for the prevention, treatment, or amelioration of pain, inflammation, or inflammation-related disorder in a subject that is in need of such prevention, treatment or amelioration, involves the administration to the subject of a cyclooxygenase-2 selective inhibitor or prodrug thereof and enteric coated aspirin. A method can also involve the administration of a cyclooxygenase-2 selective inhibitor and aspirin in an amount lower than 75 mg/day. A method can also involve the administration of a cyclooxygenase-2 selective inhibitor and aspirin where the cycloxygenase-2 selective inhibitor is BMS-347070, S-33516, CS-502, darbufelone, LAS 34475, LAS 34556, L-745337, SD-8381, RWJ-63556, L-784512, COX-189, ABT-963, or valdecoxib, or any pharmaceutical salt or prodrug thereof. Compositions, pharmaceutical compositions and kits that can be used with the methods are also described.
申请公布号 US2003207846(A1) 申请公布日期 2003.11.06
申请号 US20030337760 申请日期 2003.01.07
申请人 PHARMACIA CORP 发明人 MACMILLAN STEPHEN P
分类号 A61K45/00;A61K9/00;A61K9/16;A61K9/20;A61K9/22;A61K9/48;A61K31/365;A61K31/381;A61K31/415;A61K31/42;A61K31/444;A61K31/60;A61K31/616;A61K31/621;A61K45/06;A61P1/02;A61P1/04;A61P1/12;A61P3/10;A61P5/14;A61P7/02;A61P7/06;A61P9/00;A61P9/10;A61P9/14;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/04;A61P19/06;A61P19/08;A61P21/00;A61P21/04;A61P25/00;A61P25/04;A61P25/06;A61P27/02;A61P29/00;A61P29/02;A61P31/10;A61P31/18;A61P31/22;A61P35/00;A61P37/02;A61P43/00;(IPC1-7):A61K31/418 主分类号 A61K45/00
代理机构 代理人
主权项
地址